within Pharmacolibrary.Drugs.ATC.J;

model J01AA05
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.77,
    Cl             = 0.041666666666666664,
    adminDuration  = 600,
    adminMass      = 0.25,
    adminCount     = 1,
    Vd             = 0.0013,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0013333333333333333,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Metacycline is a tetracycline antibiotic once used in human medicine for bacterial infections. Its use has been discontinued or replaced in most countries due to availability of safer or more effective alternatives. It is not approved for current clinical use in most jurisdictions.</p><h4>Pharmacokinetics</h4><p>No published clinical pharmacokinetic studies with detailed parameters are available for metacycline in humans. The following estimates are based on general tetracycline-class antibiotic properties with adjustment for metacycline's reported pharmacology.</p><h4>References</h4><ol><li>Kenneth N Agwuh, Alasdair MacGowan,Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines.,The Journal of antimicrobial chemotherapy,2006<a href='https://pubmed.ncbi.nlm.nih.gov/16816396/'>https://pubmed.ncbi.nlm.nih.gov/16816396/</a></li><li>E M Ory,The tetracyclines.,The Medical clinics of North America,1970<a href='https://pubmed.ncbi.nlm.nih.gov/4248510/'>https://pubmed.ncbi.nlm.nih.gov/4248510/</a></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end J01AA05;
